BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/24/2025
-
GuruFocus
10/24/2025
-
Business Wire
10/9/2025
-
GuruFocus
10/9/2025
-
Globe Newswire
10/8/2025
-
Seeking Alpha: Transcripts
10/8/2025
-
Seeking Alpha: Transcripts
10/8/2025
-
SeekingAlpha
9/26/2025
-
GuruFocus
9/26/2025
-
Globe Newswire
9/2/2025
-
Ticker Report
8/29/2025
-
TipRanks Financial Blog
8/29/2025
-
The Fly
8/13/2025
-
GuruFocus
8/13/2025
-
Globe Newswire
8/11/2025
-
GuruFocus
8/11/2025
-
GuruFocus
8/11/2025
-
Globe Newswire
8/9/2025
-
TipRanks Financial Blog
8/8/2025
-
GuruFocus
8/8/2025
-
Seeking Alpha - Healthcare
8/8/2025
-
GuruFocus
8/8/2025
-
GuruFocus
8/8/2025
-
GuruFocus
8/8/2025
-
The Fly
8/8/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, August 15, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
775 888 3162
Address
680 W. Nye Lane
Carson City, NV 89703
Carson City, NV 89703
Country
Year Founded
Business Description
Sector
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The...
more